Full Breakdown
Lambert High School Students Innovate Lyme Disease Detection Using CRISPR
12/1/2025, 1:26:24 PM
Groundbreaking Research on Lyme Disease
A team of students from Lambert High School in suburban Atlanta, Georgia, has made significant advancements in the detection and treatment of Lyme disease, a condition affecting nearly half a million Americans annually. Utilizing the gene-editing technology CRISPR, the students aimed to develop a more effective diagnostic method that could identify the disease as early as two days post-infection, compared to the two-week window typical of existing tests. Lyme disease, transmitted by infected ticks, can lead to severe complications such as arthritis, neurological damage, and heart issues if left untreated.
The Innovative Approach
The Lambert team, led by co-captains Sean Lee and Avani Karthik, focused on identifying a specific protein associated with Lyme disease. By employing CRISPR, they created a method to amplify DNA segments that reveal the presence of this protein, allowing for early detection through a simple kit-style test similar to those used for COVID-19 or pregnancy. Additionally, the team explored treatment options that shift away from conventional antibiotics, aiming instead to use CRISPR to directly target and eliminate the bacteria responsible for the disease.
Competition at iGEM
In October 2023, the Lambert team competed at the International Genetically Engineered Machine (iGEM) competition in Paris, which featured over 400 teams from around the world, including 120 from Asia. The competition is often referred to as a "science Olympics," where high school and university teams showcase their innovative projects. Lambert was the only American high school to finish in the top ten, earning recognition for their software tool while ultimately losing the grand prize to a team from Great Bay in Shenzhen, China.
Challenges and Skepticism
Despite their success, the Lambert team faced skepticism regarding the feasibility of their project. Their biotechnology teacher, Kate Sharer, expressed initial doubts about the project's high-risk, high-reward nature. However, the students persevered, conducting extensive research and collaborating with professors for feedback. Their lab, funded by local taxpayers and corporate donors, provided them with resources typically found in college-level facilities.
Official Statements & Responses
Drew Endy, a Stanford professor and co-founder of iGEM, acknowledged the potential of the Lambert team's work, stating, "This year they appear to have developed a better diagnostic for Lyme disease than anything I've seen before." Endy emphasized the importance of maintaining a strong presence of young American leaders in biotechnology, especially as competition from countries like China intensifies.
Criticism & Opposition
While the Lambert team's achievements were celebrated, concerns were raised about the broader implications of America's declining leadership in biotechnology. Janet Standeven, who previously taught at Lambert and helped establish its iGEM program, lamented the loss of federal funding for synthetic biology initiatives, which she described as "necessary work."
What's Next
The Lambert team’s innovative approach to Lyme disease detection and treatment could pave the way for significant advancements in medical diagnostics. As they continue their research, the potential impact of their findings on public health remains a focal point for future exploration in synthetic biology.
